Respiratory

The attending pathologist slides a section of lung parenchyma under the scope; scattered across the lower lung field are golden-brown structures shaped like rusted dumbbells. He says they are asbestos bodies, and that this patient worked at a shipyard thirty years ago. Licensing-exam questions on respiratory pathology look at first like clues matched to diagnoses, but the reliable approach is to ask why each clue looks the way it does. Asbestos fibers are long and thin; a macrophage swallows one but cannot digest it, so it wraps the fiber in an iron-protein shell — the fiber stays locked inside yet keeps driving signals of chronic inflammation and direct genetic damage, and thirty years later that writes out three entirely different-looking diseases: pleural fibrous plaques, diffuse fibrosis, and mesothelioma.

This is also why exams love to ask what is associated with asbestos: the correct answer is the set of plaques, mesothelioma, and lung epithelial carcinoma, with pulmonary lymphoma as the exception that sits outside this causal chain. Another counterintuitive point is that asbestos bodies are not necessarily visible within the mesothelioma tumor tissue itself — the bodies are mostly found in the adjacent normal lung parenchyma; they only prove this person was exposed to asbestos, not that this tumor's cells were transformed by it. Silicosis favors the upper lobes, shows eggshell calcification, and raises the risk of tuberculosis; coal worker's pneumoconiosis is coal macules plus progressive massive fibrosis. Put the three occupational diseases together and they become three variations on the same theme: a foreign particle is swallowed by a macrophage, cannot be digested, and writes itself out as chronic inflammation and fibrosis — the only difference is which particle it is and what size determines where it lodges.

Lung cancer does not need to be memorized as a list; understand three things and you can derive it yourself: location, the histologic afterimage, and paraneoplastic or molecular markers. Location is decided by cell of origin — a peripheral tumor arising from small-airway glandular cells is adenocarcinoma or large cell carcinoma, a central tumor arising from the squamous or neuroendocrine cells of the main bronchus is squamous cell or small cell carcinoma. The histologic afterimage is what the cell originally "wanted to become" — squamous cell wants to be skin, so it forms keratin pearls and intercellular bridges; adenocarcinoma wants to be a secretory gland, so it makes mucin and is TTF-1 positive; small cell wants to be a neuroendocrine cell, so it expresses synaptophysin and chromogranin plus a whole repertoire of paraneoplastic syndromes. So peripheral plus non-smoker plus EGFR is adenocarcinoma, central plus smoker plus keratinization is squamous cell carcinoma, and central plus a paraneoplastic syndrome such as SIADH, Cushing, or Lambert-Eaton is small cell carcinoma, which is not treated surgically. Squamous cell favors the center, correlates most strongly with smoking, and secretes PTHrP to raise serum calcium — a link worth connecting to the hypercalcemia differential in the endocrine volume.

Emphysema and asthma pay off best studied together, because both present as unable to exhale, yet their mechanisms are opposite. Emphysema's core is an imbalance between proteases and antiproteases: cigarette smoke and infection recruit neutrophils and macrophages into the lung, they release elastase and matrix metalloproteinases, and normally α1-antitrypsin applies the brakes — when the brakes fail, elastic fibers are worn through, the acinus permanently dilates, lung recoil falls, and expiratory airflow becomes limited. So young, non-smoking, lower-lobe emphysema should immediately suggest the panacinar pattern of α1-AT deficiency; the ordinary smoker shows the upper-lobe centriacinar pattern; the young person's subpleural pattern is called paraseptal, a common source of spontaneous pneumothorax. The source of the proteases is neutrophils and macrophages, not lymphocytes and not eosinophils — a frequently swapped trap. Asthma runs the opposite direction: repeated inflammation and bronchoconstriction cause airway remodeling — epithelial shedding, subbasement-membrane fibrosis, submucosal gland hyperplasia, vascular proliferation, and the finding most often reversed on exams, smooth muscle hypertrophy, not atrophy, because it is trained thick from being worked every day.

On the interstitial lung disease side, do not reflexively attribute every ILD to smoking just because you see the word interstitial. Desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis are all strongly linked to smoking, but sarcoidosis is caused by environmental antigens, and smokers actually get it less often. Primary ciliary dyskinesia is a dynein arm defect; mucus cannot clear, so patients suffer recurrent bronchitis, bronchiectasis, sinusitis, and infertility, and when paired with situs inversus it is called Kartagener syndrome. For suppurative lesions, learn to split cavitation into four types: lung abscess is a round cavity with yellow pus and a thick, regular fibrous wall; a tuberculous cavity is caseous with an irregular wall; cavitary lung cancer is a necrotic tumor with thick, irregular malignant tissue; lobar pneumonia is consolidation without cavitation.

Moving out from the lung parenchyma, the next stop is the mediastinum. The exam question first localizes anterior, middle, or posterior, and the list of candidates surfaces on its own. The anterior mediastinum is remembered by the 4 T's — thymoma, teratoma, lymphoma, thyroid — of which thymoma is the most common anterior mediastinal mass in adults, and the classic tell is myasthenia gravis, pure red cell aplasia, or hypogammaglobulinemia; the middle mediastinum holds lymphoma and bronchogenic or pericardial cysts; the posterior mediastinum is almost always a neurogenic tumor growing along the sympathetic chain and neural foramina. The true mechanism of secondary pulmonary hypertension is a rise in pulmonary vascular resistance or retrograde transmission of left-heart pressure — left heart failure, mitral valve disease, the hypoxic vasoconstriction of COPD and ILD, chronic thromboembolic disease, portal hypertension, and scleroderma all count, but pericardial tamponade does not, because it is external compression of the ventricle obstructing diastolic filling — right heart pressure is squeezed out by an external force, and pulmonary vascular resistance has not actually risen. The timing of stridor is another small but frequently tested detail: the extrathoracic upper airway gets sucked flat by negative pressure on inspiration, so inspiratory stridor corresponds to upper-airway narrowing such as bilateral vocal cord paralysis or epiglottitis; the intrathoracic lower airway gets squeezed flat as intrathoracic pressure rises on expiration, so expiratory wheeze corresponds to lower-airway obstruction such as asthma or COPD; biphasic stridor is a fixed obstruction such as subglottic stenosis or a tracheal ring. Listening to the timing first is far more accurate than reflexively reaching for a bronchodilator.

The final master key is the three-step pulmonary function algorithm. Step one checks the post-bronchodilator ratio of FEV1 to FVC — below 0.70 is obstruction; step two checks total lung capacity, TLC — below 80% predicted is restriction, and the key point is that a low FVC can also result from gas trapping during obstruction, so relying on FVC alone will fool you: restriction must be confirmed by TLC. Step three checks DLCO — a low value means the alveolar wall or capillary surface area is damaged, a normal value means the lung parenchyma itself is fine and simply being squeezed or unable to move air. DLCO is the true localizer: obstruction plus low DLCO is emphysema, obstruction plus normal DLCO is asthma, restriction plus markedly low DLCO is pulmonary fibrosis, restriction plus normal DLCO plus a reduced maximal inspiratory pressure is neuromuscular disease, and restriction plus normal DLCO plus normal maximal inspiratory pressure but a deformed chest wall is thoracic restriction such as scoliosis, ankylosing spondylitis, or obesity. The positive criterion for bronchodilator testing requires both conditions at once: after inhaled SABA, FEV1 or FVC rises by at least 12% and at least 200 mL — the commonly tested slip is forgetting that 200 mL clause. A positive test supports asthma; COPD is usually irreversible, though a minority can show a response, so reversibility alone cannot rule out COPD. Hold this key firmly, and in the chapter on airway disease that follows you will find that every branch point was already decided by these three steps.

Three breathless patients arrive back to back in clinic: a sixty-eight-year-old lifelong smoker who gets short of breath climbing two flights of stairs, a twenty-two-year-old female student who coughs through the night and cannot sleep, and a heavyset middle-aged man with a 45 cm neck circumference who snores like thunder and stops breathing in his sleep. All three are unable to exhale, yet their causal threads are entirely different. Telling them apart means starting from the essential nature of each of the three storylines — COPD, asthma, and sleep-disordered breathing.

The essence of COPD is persistent airflow limitation from long-term exposure, and that airflow limitation is only confirmed once the post-bronchodilator ratio of FEV1 to FVC falls below 0.70 — this is the definition, and it cannot be replaced by a CT scan, symptoms, or clinical impression. Resistance sits mainly in the small airways, so early GOLD 1–2 patients may auscultate as entirely normal at rest, and the most common early symptom is chronic cough, not wheeze. GOLD grades 1 through 4 by percent-predicted FEV1, but since 2023 initial therapy is no longer chosen on FEV1 alone — it now follows symptoms and exacerbation history, split into three groups, A, B, and E. Group A has few symptoms and few exacerbations, so one bronchodilator suffices; group B has more symptoms but few exacerbations, so LABA and LAMA are started together immediately; group E takes in anyone with frequent exacerbations regardless of symptom burden, starting immediately on LABA plus LAMA, with ICS added once eosinophils reach 300 or more. This is also why the statement "COPD inflammation is only neutrophils plus macrophages" is wrong — CD8 T lymphocytes are involved too, and in some patients eosinophils rise as well; this group responds especially well to inhaled corticosteroids, which is exactly the basis for today's refined treatment choices. In the stable phase, LABA and LAMA form the foundation, and ICS is added only when eosinophils are 300 or higher with recurrent exacerbations; below 100, adding a steroid brings little benefit and even raises pneumonia risk. Pulmonary rehabilitation is often underrated but actually has very strong supporting evidence — it improves exercise tolerance and quality of life and reduces acute exacerbations and hospitalizations, so calling it "of limited benefit" is wrong; IV theophylline, by contrast, has weak evidence and is not recommended for routine use.

Management of an exacerbation can be memorized as a single checklist of evidence-based versus unsupported measures. The evidence-based measures are combined short-acting inhaled bronchodilators, five days of systemic corticosteroids, antibiotics when indicated, non-invasive positive pressure ventilation when necessary, and controlled oxygen targeting an SpO2 of 88 to 92. The unsupported or weakly supported measures are routine IV theophylline, routine mucolytics, and high-flow pure oxygen. Why must oxygen be controlled rather than given as high-flow pure oxygen? Because in a chronically hypercapnic patient, too high an FiO2 blunts hypoxic respiratory drive, adds the Haldane effect, and releases hypoxic pulmonary vasoconstriction, worsening V/Q matching — together these three mechanisms actually raise CO2 and cloud consciousness. The roles of diagnostic tools must also be kept straight: pulmonary function testing is required for diagnosis, and high-resolution CT can both assess the extent of emphysema and diagnose bronchiectasis, so "CT cannot diagnose bronchiectasis" is a frequently tested reversal — the signet ring sign on imaging is its signature; the α1-antitrypsin level is checked only in the specific setting of young, non-smoking, lower-lobe emphysema; bronchoscopy is not routine.

The biggest contrast between asthma and COPD is one word: reversibility. Its essence is chronic eosinophilic airway inflammation producing airway hyperresponsiveness, so any trigger causes reversible bronchoconstriction. The mechanistic chain is a favorite exam topic: injured epithelium releases TSLP, IL-25, and IL-33 — three alarmins acting like fire alarms — summoning ILC2 and Th2 cells, an unruly fire brigade; downstream, IL-5 pulls eosinophils into the tissue while IL-4 and IL-13 switch on IgE production and drive mucus secretion and airway hyperresponsiveness, and IL-13 and IL-4 also induce epithelial nitric oxide synthase, which is why FeNO rises. This pathway is Th2, not Th1 — IL-10 and IL-12 are anti-inflammatory and pro-Th1 and must never be written into it. Diagnosis rests on demonstrating reversible airflow obstruction, and the number the exam loves most is this: after inhaled SABA, FEV1 must rise by at least 12 percent and at least 200 mL, both conditions required at once — forgetting that 200 mL clause is the most commonly tripped landmine. When pulmonary function is normal but the clinical picture still looks like asthma, switch to a methacholine challenge instead; for home or occupational asthma, use peak-flow diurnal variability; FeNO is adjunctive, not diagnostic. Control grading checks four items over the past four weeks: zero items is well controlled, one to two is partly controlled, three to four is uncontrolled — so using a rescue inhaler three to four times a week plus waking at night is already not well controlled. The key treatment concept is that every adult asthma regimen must include an inhaled corticosteroid, and SABA is never used alone again — rising SABA use signals worsening control, not a step up in therapy. For partly controlled disease, the standard answer is almost always adding regular LABA to form a fixed ICS-LABA combination, not more SABA and not jumping straight to oral steroids. Stepping down requires three months of stability, not two. The most frequently tested "false contraindications" in special populations include pregnancy, where inhaled corticosteroids are safe and should be continued, with budesonide carrying the most evidence; general anesthesia and intubation are not contraindicated in well-controlled patients; aspirin-exacerbated respiratory disease can still be managed with an inhaled corticosteroid plus a leukotriene modifier; and the primary treatment for allergic bronchopulmonary aspergillosis is actually oral corticosteroids, not a contraindication. Strip away these reflexive "contraindication" answers once, and the questions become simple.

The third storyline is sleep-disordered breathing. The core distinction among its three types comes down to a single question: is respiratory effort still present? The obstructive type is upper-airway collapse — the chest and abdomen keep moving but air cannot get through, so respiratory effort is present; the central type is the brain failing to issue the command, so even the effort disappears; obesity hypoventilation syndrome is hypoventilation driven by obesity and often coexists with the obstructive type, and the patient is already hypercapnic while awake, with a carbon dioxide partial pressure of 45 or higher — that is its signature. Diagnosis relies on polysomnography to calculate the AHI, and the threshold splits into two lines depending on symptoms: with symptoms, 5 or higher counts; without symptoms, it must reach 15 or higher; severity is cut at two thresholds, 15 and 30, so the claim "OSA always requires an AHI above 15" is wrong. The trap most often swapped in is treating BMI as a severity measure — BMI is only a risk factor; severity is read from the AHI, the oxygen desaturation index, the lowest nighttime oxygen saturation, and the daytime sleepiness score, not from body weight. The reason this condition must be treated is that intermittent hypoxia plus sympathetic overactivation can produce resistant hypertension, arrhythmia, pulmonary hypertension, right heart failure, metabolic syndrome, and daytime sleepiness severe enough to cause a car accident — so obstructive sleep apnea is a common, treatable cause of secondary hypertension. First-line treatment for moderate-to-severe obstructive disease is CPAP, which props the airway open like a pneumatic splint; mild disease can first try weight loss, side-sleeping, and avoiding alcohol and sedatives; an oral appliance is used when CPAP is not tolerated, and surgery when the anatomic obstruction is clear. Obesity hypoventilation syndrome instead needs CPAP or nocturnal BiPAP plus weight loss, aiming to lower the daytime PaCO2. On the differential side, avoid one trap: obesity plus a low resting SpO2 plus respiratory acidosis should not be pinned on COPD from the hypercapnia alone — think OHS plus the obstructive type first; COPD only stands once pulmonary function shows a post-bronchodilator FEV1-to-FVC ratio below 0.70 together with a smoking history. Put the three families side by side: COPD is decades of wear that will not reverse; asthma is eosinophilic inflammation that does reverse; sleep-disordered breathing is nighttime collapse of the upper airway or a central failure to command breathing at all. All three present as unable to exhale, yet each causal thread runs its own course, and naturally so does the treatment.

The red lights in the emergency department keep flashing on through the small hours: a patient with myasthenia gravis whose PaCO2 has climbed to seventy, an obese man with bilateral pulmonary infiltrates after sepsis whose P-to-F ratio is down to eighty-five, a woman on postoperative day three after a fracture with sudden one-sided leg swelling, dyspnea, and a heart rate of one hundred thirty, and a seventy-eight-year-old man who spikes a fever three days after a rib fracture. At its core, a respiratory-emergency question asks you to wire the causal chain together correctly within five minutes. Low blood oxygen may equally be a failure of gas exchange, a failure of the ventilatory pump, or the right heart collapsing under a thrombus; a thoracic lesion may equally be a leak, a flood, or something soaking in pus. Follow the single axis of mechanism dictating the order of treatment, and emergency questions actually become easier than chronic-disease ones.

Acute respiratory failure splits into two types, and the watershed is the carbon dioxide partial pressure alone. Type 1 is a gas-exchange disorder — PaO2 falls while PaCO2 is normal or low — and pneumonia, pulmonary edema, ARDS, and pulmonary embolism all fall here; type 2 is a failed ventilatory pump — PaO2 falls and PaCO2 rises — covering the respiratory center, nerves, muscles, chest wall, and airway, so myasthenia gravis plus a high CO2 is always type 2, never the hypoxemic type. NIPPV's two evidence-based indications are AECOPD with hypercapnia and cardiogenic pulmonary edema, and the biggest misconception is treating a high PaCO2 as a contraindication — exactly the opposite, that is the very reason to use it, because NIPPV's goal is to improve ventilation and bring CO2 down. The real contraindication is a patient who cannot cooperate: coma with an unprotected airway, shock with unstable blood pressure, copious secretions or vomiting that risk aspiration, or facial trauma that prevents a mask seal. In one line, NIPPV isn't afraid of CO2 — it's afraid of a patient who can't cooperate. Distinguishing ARDS from cardiogenic pulmonary edema is a classic question: ARDS is a leak, with rising permeability and a PAWP of eighteen or below; cardiogenic edema is a flood, with rising hydrostatic pressure and a PAWP above eighteen. The Berlin definition requires four things: acute onset within one week, bilateral infiltrates, a non-cardiac cause, and severity graded by the P-to-F ratio under a PEEP of five or higher, with severe defined as one hundred or below. The core of treatment is lung-protective ventilation — a tidal volume of six milliliters per kilogram of predicted body weight, a plateau pressure below thirty, and appropriate PEEP; moderate-to-severe cases may benefit from early prone positioning, and ECMO is reserved for refractory hypoxemia. Hypoxemia with a normal chest film should bring four things to mind: pulmonary embolism, a right-to-left shunt, hepatopulmonary syndrome, and asthma — pulmonary edema does not belong on this list, because it will show up on the film.

Pleural and pneumothorax lesions can be triaged at the bedside in thirty seconds using the physical-exam triad. Decreased fremitus plus dullness is effusion; decreased fremitus plus hyperresonance is pneumothorax; increased fremitus plus dullness is consolidation. Why do breath sounds actually get louder in consolidation? A normally aerated lung acts like acoustic insulation and filters out the high-frequency components of tracheal sound; once the alveoli are filled with exudate, the tissue becomes an efficient sound-conducting medium, and the trachea's high-frequency sound carries all the way to the periphery — which is why bronchial breath sounds, increased tactile fremitus, and egophony changing E to A all appear. Any single positive Light's criterion makes it an exudate: a protein ratio above 0.5, an LDH ratio above 0.6, or an LDH above two-thirds of the upper limit of normal serum LDH. A transudate reflects a systemic problem such as heart failure, cirrhosis, or nephrotic syndrome; an exudate reflects local inflammation or malignancy, such as a parapneumonic effusion, empyema, tuberculosis, malignancy, or PE. The most discriminating indicator for draining an empyema is a pH below 7.2, and a glucose below sixty also qualifies (older teaching called a glucose below forty the strongest) — so a pH of 7.3 has not yet crossed the threshold and does not need drainage, while a glucose of twenty-eight is a screaming signal to drain immediately. For chylothorax, remember TG above one hundred ten, not cholesterol; its most common cause is chest-tube trauma or surgery, and it is an exudate. Hemothorax is defined by an effusion hematocrit above fifty percent of the peripheral hematocrit; tuberculous effusion is lymphocyte-predominant with an ADA above forty. The classic profile for spontaneous pneumothorax is a tall, thin, young male smoker with a ruptured apical bleb or bulla, presenting with sudden one-sided sharp chest pain and dyspnea. Tension pneumothorax is a true emergency — hypotension, jugular venous distension, tracheal deviation to the opposite side, hyperresonance on the affected side — it is a clinical diagnosis, and needle decompression is immediate, without waiting for an X-ray. Mesothelioma affects the pleura far more often than the peritoneum, at roughly four to five to one, carries a poor prognosis with a median survival of twelve to eighteen months, and has a low cytology yield, often requiring thoracoscopic biopsy. Thoracic ultrasound can visualize pleural effusion, pneumothorax, and diaphragmatic paralysis, but the mediastinum and deep hilar lymph nodes are blocked by aerated lung and bone and cannot be seen — those require CT, PET-CT, or mediastinoscopy.

The essence of pulmonary embolism is that a venous thrombus, usually originating in the deep veins of the leg, travels with the bloodstream and lodges in the pulmonary artery: the cross-sectional area of the pulmonary vascular bed collapses, pulmonary vascular resistance spikes, and right-heart afterload surges. The dilating right ventricle pushes the interventricular septum leftward and compresses the left heart, cutting left-heart preload and collapsing cardiac output; the dilated right ventricle's own coronary perfusion then falls, causing ischemia and a further drop in contractility — a vicious cycle. So the cause of death in a massive pulmonary embolism is not drowning — it is the right heart bursting under pressure, and shock from right-heart failure is the correct answer (called cardiogenic on the exam, classified as obstructive shock). The clinical triad is dyspnea, the most common finding, plus pleuritic chest pain plus tachycardia; one-sided leg swelling points to a DVT source, while bilateral leg swelling instead suggests heart failure or hypoalbuminemia; the most common ECG finding is sinus tachycardia, and the classic S1Q3T3 pattern along with new-onset right bundle branch block suggests right-heart strain, while the arterial blood gas shows hypoxemia plus low carbon dioxide plus respiratory alkalosis. The key to the diagnostic pathway is probability first, then blood tests, then imaging: clinical probability uses Wells' criteria, low probability uses D-dimer to exclude PE, high probability or a positive D-dimer proceeds to CTPA, and hemodynamic instability that prevents transport calls for bedside echocardiography to look for right-heart dilation. D-dimer is a rule-out tool, not a diagnostic one — highly sensitive but poorly specific, used to sweep low-probability patients off the list; diagnosis is confirmed by CTPA. The seven Wells items hide a favorite trap: plain chest pain is not one of the scored items, so don't score it as one. Risk stratification dictates treatment: high risk means sustained hypotension, and the first-line treatment is systemic thrombolysis, with catheter-directed or surgical embolectomy when that is contraindicated; intermediate risk means normal blood pressure but right-heart dysfunction, managed mainly with anticoagulation under close monitoring; low risk means normal blood pressure and a normal right heart, managed with anticoagulation, and outpatient treatment may be considered. The counterintuitive point about duration of therapy is that unprovoked cases actually carry the highest recurrence risk and need long-term or indefinite anticoagulation, because whatever caused it will come back and nothing is holding it off; provoked cases can stop anticoagulation after about three months once the transient factor has resolved.

The final piece is pneumonia and bronchiectasis. The first cut in classifying pneumonia is where it was acquired and who the host is: community-acquired disease is most often Streptococcus pneumoniae, hospital-acquired disease trends toward gram-negative and resistant organisms, ventilator-associated disease follows the same pattern as hospital-acquired but with even higher resistance, and aspiration pneumonia trends toward anaerobes and oral flora. CURB-65 grades severity. The numbers in the VAP-prevention bundle are the favorite target for substitution: raising the head of the bed thirty to forty-five degrees is correct, sixty degrees is wrong — remember thirty-to-forty-five is right, sixty is way too much. The segments favored by aspiration pneumonia and lung abscess are determined by position: the supine position is most common, and aspirated material flows into the gravity-dependent zones — the posterior segment of the right upper lobe plus the superior segments of both lower lobes; the right middle lobe and lingula are not gravity-dependent zones and are not favored sites, which is the licensing exam's favorite substitution here. The core true risk factors for aspiration are problems with swallowing or esophageal motility: systemic sclerosis loosens the lower esophageal sphincter and disrupts motility, causing reflux and aspiration; Parkinson disease impairs coordination of the swallowing muscles; stroke, altered consciousness, and esophageal stricture all count too; pulmonary fibrosis does not affect swallowing and does not count, and asplenia raises the risk of infection by encapsulated organisms but is not an aspiration risk factor. The imaging signature of bronchiectasis is the tram-track sign and the signet-ring sign, favoring both lower lobes. Diffuse causes are primary ciliary dyskinesia, cystic fibrosis, hypogammaglobulinemia, allergic bronchopulmonary aspergillosis, and recurrent aspiration; focal causes are foreign body or tumor obstruction, pulmonary sequestration, and recurrent infection confined to a single segment. So when a question asks which is the least appropriate cause of diffuse bronchiectasis, the answer is pulmonary sequestration, because it produces focal bronchiectasis, not a diffuse process. When a focal lesion cannot be controlled with antibiotics against recurrent infection or massive hemoptysis, lobectomy or segmentectomy may be considered — bronchiectasis is not always managed medically alone. Last is the causal chain from rib fracture in the elderly to pneumonia: pain keeps the patient from breathing deeply or coughing effectively, sputum retention and atelectasis follow, and retention or aspiration pneumonia results — so the key management is effective analgesia, including epidural analgesia, plus chest physiotherapy, giving the older patient the confidence to cough and breathe deeply, which is the real foundation of pneumonia prevention rather than reflexively reaching for a course of prophylactic antibiotics. The whole chapter comes down to one principle: ask the mechanism first, then decide the order of treatment.

This chapter really asks only one thing: what is this shadow in the lung, why does it grow exactly where it does, and why does it produce the sound it does. Hold onto that question, and the path from lung cancer to tuberculosis, to interstitial lung disease, to pediatric acute airway disease, to rehabilitation turns out to be one continuous chain of reasoning.

The first cut in lung cancer falls between small cell and non-small cell. Small cell lung cancer is almost always linked to smoking, grows centrally, and has usually metastasized by the time it's found, so treatment relies mainly on chemotherapy plus radiotherapy with surgery rarely an option — yet it responds well to chemoradiotherapy, and it commonly comes with SIADH, ectopic-ACTH-driven Cushing syndrome, and Lambert-Eaton syndrome, because its neuroendocrine origin is exactly why it produces these hormones. Non-small cell lung cancer splits into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma grows peripherally, is most common in nonsmokers and women, and is tied to EGFR and ALK mutations — which is why oral targeted drugs exist for it; its lepidic subtype spreads along the alveolar walls without stromal or vascular invasion, giving it the best five-year survival near 100% after complete resection, while micropapillary and solid subtypes carry the worst prognosis. Squamous cell carcinoma runs the opposite way — strongly linked to smoking, centrally located, prone to cavitation, and it secretes parathyroid-hormone-related protein that causes hypercalcemia, so the paraneoplastic syndrome behind hypercalcemia is squamous cell carcinoma, not small cell — get that pairing backwards and you lose points on the exam. A tumor's local spread syndromes simply follow whatever structure it touches: a Pancoast tumor at the apex compressing the brachial plexus causes shoulder and arm pain with hand wasting; compressing the cervical sympathetic chain further up causes the Horner triad, so Horner's syndrome comes from the cervical sympathetic chain, not the phrenic nerve — phrenic nerve invasion instead causes diaphragmatic paralysis; a left hilar tumor compressing the left recurrent laryngeal nerve causes hoarseness; and the superior vena cava being encased causes SVC syndrome with facial and upper-limb edema. The apex is hidden behind the clavicle and upper ribs, so a lordotic X-ray is needed to move the clavicles up out of the way. A monophonic wheeze comes from a single large airway obstructed by a fixed lesion with unchanging pitch, most commonly lung cancer, unlike the polyphonic wheezing of asthma. Clubbing plus hypertrophic osteoarthropathy is again most commonly bronchogenic carcinoma, linked to excess VEGF and PGE2. Absolute contraindications to curative resection are SVC syndrome, malignant pleural or pericardial effusion, contralateral mediastinal nodes, and distant metastasis; an FEV1 over one liter, ipsilateral hilar N1 nodes, and stable angina are not absolute contraindications. First-line therapy for extensive-stage SCLC is systemic chemotherapy combined with immunotherapy, and mild SVC compression does not require emergency radiotherapy.

Understanding tuberculosis means understanding its natural history. Primary infection usually settles in the mid-to-lower lung, and the organism disseminates hematogenously and lies dormant throughout the body; once immunity falls, it reactivates in the upper lung zones where oxygen tension is highest, because the tubercle bacillus is an obligate aerobe — so reactivation cavitation and fibrosis favor the upper lung zones, especially the posterior segment of the right upper lobe. Latent infection is diagnosed by TST or IGRA, and since both measure cell-mediated immunity, neither can distinguish latent from active disease; latent infection is not contagious, needs no mask, progresses in roughly 10% of cases over a lifetime, and treatment can cut that rate by 60–90%. Tuberculous pleural effusion is not the bacillus attacking directly — it's an exudate driven by a type IV delayed hypersensitivity reaction, so lymphocytes exceed half the cell count, mesothelial cells are scarce, and an ADA of 40 or higher is suggestive. The standard four-drug RIPE regimen carries its own set of side effects: isoniazid plus vitamin B6 prevents peripheral neuropathy, rifampin stains body fluids orange-red and induces CYP enzymes, pyrazinamide raises uric acid, and ethambutol requires watching for optic neuritis and red-green color blindness. Monitoring covers liver function plus a complete blood count, not CK. Liver enzymes under three times normal with no symptoms mean continuing treatment with close follow-up; only enzymes over three times normal with symptoms, or over five times normal, warrant stopping. The resistance genes are rpoB for rifampin, katG and inhA for isoniazid, pncA for pyrazinamide, and embB for ethambutol; MDR requires simultaneous resistance to both isoniazid and rifampin — resistance to just one does not count. BCG is effective against miliary TB and tuberculous meningitis in infants but offers poor protection against adult-type reactivation disease, so healthcare workers must rely on negative-pressure isolation and N95 respirators rather than the vaccine.

Interstitial lung disease really comes down to one mechanism explained fully: the interstitium between the alveoli and capillaries gets poured full of cement by inflammation or fibrosis, so the lung turns stiff, shrinks, and struggles to diffuse gas. Follow this chain and vital capacity falls, total lung capacity falls, DLco falls, and hypoxia appears first with exercise; the obstructive pattern has an FEV1-to-FVC ratio below 70%, while the restrictive pattern, because both fall proportionally, actually stays normal or elevated. So a patient with a total lung capacity of 70%, an FEV1/FVC of 78%, and a DLco of 55% has restrictive ILD with diffusion impairment; chest wall deformity is also restrictive but has a normal DLco, which rules it out. Sarcoidosis comes from overactivated Th1-type CD4 T cells plus macrophages forming non-caseating granulomas; the lung is involved in over 90% of cases, with bilateral hilar lymphadenopathy, and BAL shows an elevated CD4-to-CD8 ratio, often above 3.5 rather than decreased; hypercalcemia comes from macrophage 1α-hydroxylase converting vitamin D to its active form, and first-line treatment is systemic corticosteroids, though asymptomatic stage I disease often remits spontaneously without treatment. Löfgren syndrome is bilateral hilar adenopathy plus erythema nodosum plus polyarthritis, with the best prognosis. IPF's pathology is UIP with honeycombing, unresponsive to corticosteroids, requiring the antifibrotic drugs pirfenidone or nintedanib — the opposite in both prognosis and treatment from NSIP, which does respond to corticosteroids. Hypersensitivity pneumonitis involves organic antigens such as bird droppings or farmer's lung; pneumoconiosis involves inorganic dust such as silica, coal, or asbestos; occupational asthma accounts for at least 10% of adult asthma, and the prevention hierarchy ranks engineering controls above administrative controls above personal protective equipment. Eosinophilic pneumonia is confirmed the moment you see bilateral infiltrates plus a recent NSAID history plus BAL eosinophils above 25%.

Pediatric acute airway disease uses sound to localize: extrathoracic obstruction collapses under negative pressure on inspiration, giving inspiratory stridor, while intrathoracic small-airway obstruction gets compressed on expiration, giving expiratory wheezing. Croup is subglottic edema from parainfluenza virus, with a barking cough and a steeple sign on imaging; a single dose of steroid should almost always be given, nebulized epinephrine is reserved for moderate-to-severe cases, and the management principle is to keep the child calm rather than crying. Epiglottitis is infection of the epiglottis by Haemophilus influenzae type b, with drooling, a tripod position, and a thumb sign on imaging; tongue depression is forbidden, and management must occur where the airway can be secured immediately. Bronchiolitis affects children under two infected by RSV, with poor SABA efficacy and mainly supportive care. Pediatric asthma under age five cannot be diagnosed by pulmonary function testing, so diagnosis relies on history and responsiveness to SABA; the most effective controller for persistent disease is inhaled corticosteroids, LTRA is less effective, SABA is a rescue drug rather than a long-term controller, and control sustained over three months allows stepping down. Mediastinal widening at age two is most commonly a normal thymus. Allergy prevention runs opposite to intuition: no routine probiotics, no need for pregnant women to avoid highly allergenic foods, and early introduction of complementary foods including peanut from four to six months actually lowers allergy risk.

The shared logic of rehabilitation is to localize the injury first, then choose the maneuver. Spastic dysarthria comes from bilateral upper motor neuron damage, flaccid from lower motor neuron damage, ataxic from cerebellar breakdown of coordination and rhythm giving scanning speech, and hypokinetic from basal ganglia dopamine deficiency. Aphasia is a language-cortex problem while dysarthria is a muscular execution problem — the two are distinct. Swallowing depends on which phase is impaired: total glossectomy knocks out the oral phase's propulsion, so chin-up uses gravity instead, rather than the aspiration-preventing chin-tuck or the tongue-dependent Masako maneuver; the pharyngeal phase uses chin-tuck to prevent aspiration, Mendelsohn when the upper esophageal sphincter fails to open, Shaker when the suprahyoid muscles are weak, and Masako when tongue-base retraction is weak. In cardiac rehabilitation, acute inflammation and instability are contraindications while stabilized and postoperative states are indications, so a stabilized acute MI actually calls for rehabilitation; the best estimate of myocardial oxygen consumption is the double product, heart rate times systolic pressure, because these two terms map exactly onto wall tension and contraction frequency. In pulmonary rehabilitation, exertional dyspnea is an indication rather than a contraindication, expectorants should be used actively, and postoperative positioning should keep the affected side up so gravity drains secretions while the healthy side stays dependent for a better ventilation-perfusion ratio — putting the healthy lung on top is wrong. Hold onto one question through the whole chapter: what is this shadow, why does it grow there, what sound does it make — and the answer will surface.

This chapter pulls the camera back to a layer beneath the lesion itself, and every question asks the same thing: how gas and blood move through the body, and why that movement goes wrong. Hold onto this thread, and diffusion versus perfusion, Hb versus partial pressure, how CO₂ finds its way home, why forced exhalation ends up choking itself off, why the upper airway collapses during sleep, why the body clock gets pushed back, why tissues grow into the shapes they do, and finally why an aorta tears open — all of it is the same physical chain of cause and effect.

Gas exchange physics has only two bottlenecks. Diffusion-limited means the diffusion membrane can't keep pace and the blood leaves the alveolus before equilibrating — the textbook example is carbon monoxide, because it binds hemoglobin so strongly that its partial pressure never manages to rise and it never reaches saturation, so exchange depends on diffusion the whole way, which is why it's used clinically to measure DLco; nitric oxide doesn't bind hemoglobin and equilibrates right at the start of the capillary, so it is perfusion-limited. Normal oxygen and carbon dioxide are also perfusion-limited, with oxygen reaching saturation at about one-third of the way along the capillary, but during pulmonary fibrosis or exercise, when the diffusion membrane thickens or blood flow speeds up, oxygen shifts to being diffusion-limited — this is the physical reason interstitial lung disease patients become hypoxic first with exercise. The respiratory quotient equals carbon dioxide output divided by oxygen consumption; carbohydrate is highest at 1.0, because the sugar molecule is rich in oxygen and burns the cleanest; protein is 0.8, fat is 0.7.

The three blood-oxygen values each mind their own business. The dissolved oxygen partial pressure is set by alveolar ventilation; hemoglobin saturation reflects the fraction of hemoglobin occupied by oxygen; the oxygen content actually delivered to tissue is 1.34 times hemoglobin times saturation, plus a small contribution from dissolved oxygen. So in anemia, only the hemoglobin is reduced — ventilation is fine, each hemoglobin molecule is still normally saturated, dissolved oxygen and saturation are both normal, and only the oxygen content falls. Carbon monoxide poisoning, by contrast, leaves dissolved oxygen unchanged so the partial pressure is normal, but carbon monoxide occupies hemoglobin's binding sites forming carboxyhemoglobin, so saturation falls; a pulse oximeter cannot distinguish carboxyhemoglobin from oxyhemoglobin, so its reading can be falsely normal, and diagnosis requires directly measuring carboxyhemoglobin. The tool for differentiating hypoxemia is the alveolar-arterial oxygen difference: a normal gradient with a good response to supplemental oxygen points to alveolar hypoventilation or high altitude, while an elevated gradient points to V/Q mismatch, diffusion impairment, or right-to-left shunt; a shunt cannot be raised even by breathing 100% oxygen — that is the ironclad rule for shunt.

How carbon dioxide finds its way home is also a matter of physics. It enters the red blood cell, is catalyzed by carbonic anhydrase into carbonic acid, and then splits into a hydrogen ion and bicarbonate; bicarbonate leaves the red cell for the plasma through anion exchanger 1, while chloride moves in at the same time in the opposite direction — this is the chloride shift. Anion exchanger 1 is an exchanger, not a cotransporter, and that wording gets tested. During forced exhalation, intrapleural pressure can turn positive, and this positive pressure compresses the airway to produce dynamic compression, so beyond a certain point peak expiratory flow becomes effort-independent — no amount of extra effort can raise it further, which is also the physical reason COPD patients cannot blow air out. Surfactant is secreted by type II alveolar cells, lowering surface tension and preventing small alveoli from collapsing; glucocorticoids accelerate fetal lung maturation, which is why they are given before a preterm delivery. The afferent limb of the cough reflex runs through the vagus nerve plus the glossopharyngeal nerve, and the most sensitive trigger point is the carina, which is why patients cough especially hard once a bronchoscope reaches the carina.

Sleep apnea is split by whether respiratory effort persists. The obstructive type is trying to breathe but unable to draw air in, with the chest and abdomen still heaving desperately; the central type has no respiratory command issued at all, with airflow and effort stopping together; the former favors obesity and snoring, the latter favors heart failure, stroke, and opioid use. The obstructive type occurs in both light sleep and REM sleep — REM sleep, with its lowest muscle tone, worsens it, but it is not exclusive to REM. Diagnosis relies on polysomnography, and severity is graded by the apnea-hypopnea index per hour, with above 30 being severe; home sleep testing is only a screening tool. Every risk factor can be derived from narrowing the upper airway or lowering pharyngeal muscle tone: obesity, tonsillar and adenoidal hypertrophy, male sex, age, postmenopausal status, alcohol and sedatives, supine sleep, and micrognathia; mandibular prognathism, on the contrary, moves the tongue and jaw forward and enlarges the retropharyngeal space, so it is not a risk factor. Hypertension is a consequence or comorbidity, not a risk factor — the direction of causality must be kept straight. The treatment ladder's first choice is CPAP to splint open the collapsing airway; the first choice in children is tonsillectomy.

The core of circadian rhythm is the phase shift. The body clock is governed by the suprachiasmatic nucleus, and light exposure is the strongest zeitgeber. The phase response curve tells you: morning light exposure pulls the phase earlier, while evening or nighttime light exposure pushes the phase later; melatonin works the opposite way — given in the evening it advances the phase, given in the morning it delays it. Delayed sleep phase syndrome favors adolescents, with a delayed phase causing late bedtimes and late waking, so the phase needs to be pulled earlier using morning light exposure plus evening melatonin; if an exam question states that nighttime light exposure treats the delayed type, that is wrong — it would only push the phase even later. The advanced type favors the elderly, with an advanced phase.

Histology comes down to one sentence: surfaces that wear use stratified squamous for protection, surfaces that absorb and secrete use simple columnar, and surfaces that exchange gas use simple squamous. So the trachea and bronchi are pseudostratified ciliated columnar with goblet cells relying on the mucociliary elevator to clear debris; the alveoli are type I alveolar cells, simple squamous; the esophagus is nonkeratinized stratified squamous; and the appendix, like the large intestine, is simple columnar with goblet cells, not stratified squamous. Gastric parietal cells do not synthesize acid in the cytoplasm — the membrane's proton pump pumps hydrogen ions into the lumen of the intracellular canaliculi, chloride then enters, and hydrochloric acid forms right there in the lumen; proton pump inhibitors act exactly on this step. The three arterial types are classified by the tunica media: elastic arteries such as the aorta and pulmonary trunk have elastic lamellae that provide buffering, muscular arteries such as the brachial and radial arteries are dominated by smooth muscle and handle distribution, and arterioles are the main resistance vessels that determine blood pressure; the brachial artery is muscular type, not elastic type, and is frequently tested in reverse. Hepatic blood flows from the portal tract to the central vein, and oxygen declines from front to back, so Zone 3 near the central vein dies first while Zone 1 near the portal tract regenerates first — writing it backwards reverses the causality. Purkinje fibers are specialized cardiac muscle, not nerve tissue; albumin is synthesized by hepatocytes, not plasma cells; alveolar macrophages can engulf the tubercle bacillus but cannot digest it, which is why granulomas form; cystic fibrosis comes from the CFTR gene with autosomal recessive inheritance, not an acquired infection; and mitochondria have a double membrane, not a single one.

Last comes aortic dissection. An intimal tear lets blood flood into the media and create a false lumen; retrograde extension can tear into the pericardium causing tamponade, and can invade the coronary or carotid ostia, so the single core question deciding life or death is: has the ascending aorta been involved? Stanford A, involving the ascending aorta, carries a mortality that climbs every hour and requires emergency surgery; Stanford B, involving only the descending aorta, is managed primarily with medication, with intervention reserved for complications. DeBakey type II is limited to the ascending aorta alone — writing it as including the arch is wrong. Diagnosis relies on CT angiography, with transesophageal echocardiography used when the patient is unstable; intramural hematoma, with no tear and no false-lumen flow, is a precursor to dissection; a penetrating ulcer arises on a background of atherosclerosis. The three are together called acute aortic syndrome, and chest X-ray may show mediastinal widening, but a normal film cannot rule it out. The sequence of acute management follows the physics: the goal is to lower aortic wall shear stress, so a β-blocker comes first to bring down heart rate and contractility, with a target heart rate under 60, and then a vasodilator is added to bring systolic pressure down to 100 to 120; giving the vasodilator alone first causes reflex tachycardia that actually raises shear stress and accelerates false-lumen expansion, so reversing the order causes harm. Stanford A complicated by organ malperfusion carries a markedly worse prognosis than cases without malperfusion. Complicated type B favors thoracic endovascular aortic repair over open surgery. The surgical threshold for abdominal aortic aneurysm is a diameter of 5.5 cm or more, growth exceeding 0.5 cm per year, or the presence of symptoms — a larger diameter means greater tension by Laplace's law and therefore easier rupture; a pseudoaneurysm, with its wall ruptured and contained only by surrounding tissue, ruptures even more easily; a mycotic aneurysm carries the word "fungal" in its name, but its most common source of infection is actually bacterial, such as Salmonella and Staphylococcus, not fungal. Marfan syndrome is autosomal dominant, caused by an FBN1 mutation with a defect in the fibrillin-1 microfibril, producing an ascending aorta prone to dilation and dissection, along with lens dislocation, long digits, and a tall, thin build. The intra-aortic balloon pump sits in the descending aorta, 2 cm distal to the origin of the left subclavian artery; it inflates during diastole to increase coronary perfusion and deflates during systole to reduce afterload. Spinal cord protection in thoracoabdominal aortic aneurysm repair uses CSF drainage to lower spinal perfusion pressure, and both open surgery and endovascular repair benefit from it. Off-pump coronary artery bypass is not the technique used by the majority worldwide, and its long-term survival and reintervention rates show no clear advantage over conventional bypass with cardiopulmonary bypass. Hold onto one sentence and the whole chapter holds together: explain the true physics of how gas and blood move all the way through, and every test point grows straight out of that causal thread — none of it needs to be memorized by rote.

One leg slowly clogging up, one leg severed overnight, one leg swollen for years because an artery crosses over and compresses a vein — vascular surgery looks like a thousand loose threads, but it's really the same problem written three different ways. Picture every blood vessel as a river — silting, severing, compression, leaking — and every kind of wrong has its own sign, its own timeline, its own fix. The diabetic man in clinic who can't walk to the convenience store without stopping is the chronic story; the elderly woman in the ER with atrial fibrillation and no anticoagulation whose foot turned cold overnight is the acute story; the image on the conference table of a left common iliac vein flattened by the right iliac artery is the anatomic story. Line these three stories up together, and the exam points on arteries and veins, acute and chronic, fall into place on their own.

The essence of chronic peripheral arterial disease is atherosclerosis grinding the channel narrower year after year; during exercise the muscle downstream needs more oxygen than the blood supply can deliver, and the leg starts to ache — that's intermittent claudication. Narrow it further and even rest isn't enough, and it becomes ischemic rest pain; finally the tissue simply dies, and ulceration and gangrene take the stage. Arranged by degree of ischemia, this is exactly Fontaine stages one through four. Assessment relies on the ankle-brachial index, normally falling between 0.9 and 1.3, with below 0.9 meaning peripheral arterial disease. But this index hides one elegant trap: a value above 1.3 does not mean things are better — it means the vessel has calcified and hardened and can no longer be compressed, so the reading comes out falsely high, most often tripping up diabetic and kidney patients, and you should switch to the toe-brachial index instead. Treatment priority is also frequently tested: first-line therapy for simple claudication is never bypass or stenting — it's smoking cessation, controlling the three highs, antiplatelet therapy, plus supervised exercise training, with cilostazol, a phosphodiesterase inhibitor, as the drug of choice; revascularization is reserved for cases where conservative therapy fails, or for critical limb ischemia.

Acute limb ischemia wears a completely different face. Its hallmark is the six P's: pain, pallor, pulselessness, paresthesia, paralysis, and coldness, and among these, loss of sensation and motor function means the tissue is already crying for help. Why is the most common cause the heart rather than in-situ thrombosis? Because atrial fibrillation lets blood stagnate in the left atrial appendage, where a clot quietly grows, and once it breaks free it rides the aorta like a highway straight down to the limb and lodges at a bifurcation — so the trouble truly starts in the heart (though in situ thrombosis now accounts for a markedly larger share). Clinically, embolism tends to be sudden, with a normal contralateral pulse and no history of peripheral arterial disease; in-situ thrombosis, by contrast, tends to occur on old disease, propped up by collateral circulation, with milder symptoms. Restoring blood flow obviously has to happen, but ischemic, dying muscle has been stewing in metabolic waste, and restored blood flow flushes it all into the systemic circulation — potassium leaks outward causing hyperkalemia, creatine kinase and myoglobin surge causing rhabdomyolysis that damages the kidneys, lactate and hydrogen ions rise causing acidosis, and local swelling causes compartment syndrome requiring fasciotomy. The exam loves to ask "which of the following is least likely to appear during reperfusion," and the answer is always hypercalcemia, because early on it's actually hypocalcemia — fat saponification in the dying muscle pulls calcium in and deposits it there; this is a direction question — potassium leaks outward, calcium hides inside the tissue.

The central axis on the venous side is Virchow's triad — stagnant flow, vessel injury, thickened blood — and any one of the three alone can grow a clot. A frequently tested anatomic trap is called May-Thurner syndrome, also known as Cockett syndrome: the right common iliac artery crosses over and compresses the left common iliac vein, causing chronic venous outflow obstruction in the left leg, and you should think of it whenever a young woman presents with an isolated left iliofemoral clot; the exam loves to reverse the causality and write it as a complication of deep vein thrombosis, when it is actually the cause — the anatomic compression comes first, and the clot follows. The diagnostic pathway works like a series of sieves: first use the Wells score to estimate pretest probability, and if the probability is low, try to rule it out with D-dimer. This marker is a highly sensitive, poorly specific smoke detector — a negative result can exclude the diagnosis, with a negative predictive value reaching ninety-nine percent, but a positive result cannot confirm it, since inflammation, surgery, pregnancy, cancer, and older age can all raise it; a positive result or high pretest probability calls for compression Doppler ultrasound, which is the first-line tool for confirmation, with both sensitivity and specificity exceeding ninety-five percent, and when ultrasound of the pelvis and inferior vena cava segment isn't clear enough, add CT or MR venography. The downstream disaster is a clot breaking free and traveling to the lungs to cause pulmonary embolism, and proximal clots above the knee and in the iliofemoral segment embolize far more readily than those in the calf.

Don't mix up the treatments either. The standard treatment for deep vein thrombosis is anticoagulation, not emergency surgery; either a newer oral anticoagulant or low-molecular-weight heparin bridged to warfarin works, with three months for provoked disease and longer for unprovoked or cancer-associated disease, and low-molecular-weight heparin or a newer oral anticoagulant preferred when cancer is involved; catheter-directed thrombolysis or thrombectomy is added only for extensive iliofemoral disease or the limb-threatening emergency of phlegmasia cerulea dolens. The indication for an inferior vena cava filter is a contraindication to anticoagulation or recurrent pulmonary embolism despite adequate anticoagulation, and the principle is that blood flow carries the clot upward where the net catches it. One elegant exam point hides here: if the inferior vena cava is already chronically and completely occluded, blood flow has long since rerouted through collaterals, so placing a filter catches nothing and may even obstruct those collaterals — making it completely useless; a retrievable filter should be removed as soon as possible once the bleeding risk resolves. There are plenty of other peripheral details too. Bypass graft material comes down to one line — the smaller the caliber, the more it depends on an autologous vein — so infrapopliteal bypass favors the autologous great saphenous vein first, while a high-flow site like the aortoiliac segment can tolerate a prosthetic graft. Thoracic outlet syndrome favors young women and is mostly the neurogenic type, with Adson's, Halsted's, and Wright's as the three provocative tests, while the breath test is not a valid test. Carotid bifurcation stenosis classically occurs at the origin of the internal carotid artery. Traumatic carotid-cavernous fistula is usually high-flow, and the treatment of choice is endovascular embolization, without the need for open surgery. The final corner is pediatric surgery. A hemangioma is a tumor that proliferates and then involutes, usually appearing weeks after birth and not involuting until five to seven years old rather than before age one; a vascular malformation is a congenital structural error, present at birth and never involuting. Malformations are further classified by flow: low-flow venous malformations are treated with sclerotherapy, while high-flow arteriovenous malformations require embolization or surgery, since sclerotherapy is ineffective and carries a risk of reflux, and port-wine stains are treated with pulsed dye laser. Pectus excavatum is considered severe once the Haller index exceeds 3.25, the optimal surgical age is six to fourteen, operating too early instead makes recurrence more likely, and the corrective bar is left in place for two to three years. Hold onto one sentence for the whole chapter: treat every blood vessel as a river, and silting, severing, compression, and leaking each have their own fix; arrange arteries and veins, acute and chronic, in their proper sequence, and the exam points will fall into place on their own.

The heart, the thorax, and the mediastinum are three equally cramped stages, and the instant any rope snaps, any wall breaks, or any duct leaks up there, the clock starts counting down. Start with the mechanical complications after acute myocardial infarction. Why do they always strike between day two and day seven? Because ischemic myocardium first softens after it dies, and during that window the structure is at its weakest — any stress and it tears. Remember the three classics by anatomic site: free wall rupture is the wall breaking — the heart's outer shell tears, blood floods the pericardium, tamponade follows, then pulseless electrical activity, then sudden death; ventricular septal defect is the septum breaking — the wall between the left and right ventricles tears, producing a left-to-right shunt, pulmonary edema, and shock, with a holosystolic murmur audible at the lower left sternal border; papillary muscle rupture is the rope snapping — the cord holding the mitral valve tears, causing acute severe regurgitation and acute pulmonary edema, with a holosystolic murmur at the apex that unfortunately is not always obvious. The favorite exam trap is that acute aortic regurgitation is not one of these three — it is linked instead to aortic dissection and endocarditis.

The intra-aortic balloon pump is an elegant device: it inflates in diastole to push blood back toward the aortic root and perfuse the coronaries, then deflates in systole just before the aortic valve opens, lowering afterload and cardiac work. But the IABP-SHOCK II trial told us that in patients with acute myocardial infarction complicated by cardiogenic shock, placing one does not improve 30-day survival, so isolated shock is not a good indication for it; yet when a mechanical complication such as a septal defect or acute mitral regurgitation is waiting for surgery, it becomes an indispensable bridge, lowering afterload and stabilizing hemodynamics. One setting is ineffective, the other essential — the difference lies in what is being treated. Its contraindications must be memorized cold too: moderate-to-severe aortic regurgitation, because using it worsens the regurgitation; aortic dissection, an absolute no; and severe peripheral arterial disease, which also makes it unsuitable. For bypass surgery under cardiogenic shock, the preference actually shifts to on-pump rather than off-pump, because stable perfusion is safer; off-pump requires manipulating the heart, and that carries high risk in an extremely unstable patient. Emergency life-saving care carries one more easy ethics point: when a patient is unconscious and no family member can be found, an immediately life-threatening situation allows treatment under presumed consent — do not delay simply because no signature can be obtained.

The primary survey in thoracic trauma has four immediately lethal injuries that must be ruled out on the spot: tension pneumothorax, open pneumothorax, massive hemothorax, and cardiac tamponade. The highest-yield distinction lies between the first of these and cardiac tamponade. The signature of tension pneumothorax is absent breath sounds on the affected side, hyperresonance, and tracheal deviation to the opposite side, plus jugular venous distension and hypotension. The signature of cardiac tamponade is Beck's triad — hypotension, jugular venous distension, and muffled heart sounds — but with breath sounds symmetric on both sides. The catch is that jugular venous distension and hypotension appear in both, so these two signs cannot be used to distinguish them at all; the true distinguishing feature is whether the breath sounds are symmetric: asymmetric with absence on the affected side means tension pneumothorax, symmetric with muffled heart sounds means cardiac tamponade. The management principle is treat first, image later — when hemodynamics are unstable, do not wait for a chest X-ray; go straight to needle decompression. The traditional site is the second intercostal space at the midclavicular line; the newer guideline recommends switching to the fourth or fifth intercostal space at the anterior or midaxillary line in adults, because the chest wall is thinner there and decompression is more reliable, followed by a chest tube at the fifth intercostal space, midaxillary line. Hemothorax is judged by the numbers to decide whether to operate: immediate output over fifteen hundred milliliters on tube insertion, or sustained output over two hundred milliliters per hour for three to four hours, or persistently unstable vital signs — any of these calls for thoracotomy; five hundred milliliters sounds like a lot, but if vital signs have stabilized, surgery is not required — this is a common numerical trap.

The esophagus is a tube that is very easy to overlook. A penetrating wound plus subcutaneous or mediastinal emphysema should immediately raise suspicion of esophageal or tracheal injury; the esophagus sits behind the trachea, so the two are often injured together, and a missed diagnosis progresses to mediastinitis with high mortality — so the esophagus must always be checked, using a water-soluble contrast esophagram or endoscopy. Boerhaave rupture occurs when violent vomiting causes a sudden surge in intraesophageal pressure, tearing full-thickness at the weakest point in the distal left posterolateral wall; Mackler's triad is vomiting plus chest pain plus subcutaneous emphysema; gastric contents and oral flora entering the mediastinum produce acute mediastinitis, empyema, and sepsis; surgery is mandatory (the exam answer; contained, stable perforations may now be managed nonoperatively or endoscopically), and a delay beyond twenty-four hours pushes mortality as high as fifty to seventy percent — treat it as the esophageal version of an acute myocardial infarction, where minutes cost lives. At the other end of life, in the newborn, is esophageal atresia with tracheoesophageal fistula; the most common Gross type C accounts for eighty-five percent, presenting clinically with frothy saliva plus upper abdominal distension, a nasogastric tube that coils in the upper esophagus on insertion, and prenatal polyhydramnios. The trap lies in the sequence of management: stabilize vital signs first and screen for associated anomalies, the heart above all, before proceeding to elective surgery — not operating the moment it is seen — because the cardiac anomaly is the most critical of the associated findings, which is exactly why VACTERL must be checked item by item.

Mediastinal tumors are judged by compartment. The anterior mediastinum carries the four T's — thymoma, teratoma and germ cell tumors, retrosternal thyroid, and terrible lymphoma; the middle mediastinum holds lymph nodes and cysts; the posterior mediastinum holds neurogenic tumors. The standard for thymoma is complete surgical resection — even when it invades the superior vena cava, reconstruction and resection are still worthwhile — and the Masaoka system stages it by capsular and surrounding invasion. Do not flip the direction: thirty to fifty percent of thymoma patients have concurrent myasthenia gravis, but in reverse, only ten to fifteen percent of myasthenia gravis patients have a thymoma; thymectomy improves the myasthenia, so every myasthenia patient should be screened for an anterior mediastinal mass. Mediastinal germ cell tumors split into two branches: seminoma does not secrete alpha-fetoprotein, and beta-hCG is rarely elevated either, yet it is highly sensitive to chemoradiation; non-seminomatous germ cell tumor shows both alpha-fetoprotein and beta-hCG elevated, and treatment is chemotherapy plus resection of any residual mass. So an elevated alpha-fetoprotein is never pure seminoma, and a seminoma with a high beta-hCG should raise suspicion of a mixed tumor. The downstream story of gastroesophageal reflux disease is likewise a clean causal chain: chronic gastric acid reflux causes the squamous epithelium of the distal esophagus to be replaced by intestinal metaplasia — Barrett epithelium, containing goblet cells — which then progresses to dysplasia and esophageal adenocarcinoma; so the resulting malignancy is adenocarcinoma, not squamous cell carcinoma, which is a different disease tied to smoking, alcohol, and hot beverages and which favors the mid-to-upper esophagus instead. Do not flip the angles of antireflux surgery either: Nissen is a full three-hundred-sixty-degree wrap, not partial; Toupet is a two-hundred-seventy-degree posterior partial wrap; Dor is a one-hundred-eighty-degree anterior partial wrap. The treatment sequence still places lifestyle modification plus a proton pump inhibitor as first-line therapy, with surgery reserved for those refractory to medication or with complications.

Chylothorax closes the chapter with one more anatomy question. The thoracic duct ascends along the right side of the spine and crosses to the left only at the fourth to fifth thoracic vertebrae, so most thoracic duct injuries occur on the right — surgery must approach through a right thoracotomy for ligation to catch the point of disruption, which is exactly why the answer is right, not left. The pleural fluid is characterized by triglycerides above one hundred ten, the presence of chylomicrons, a predominance of lymphocytes rather than eosinophils, and a milky appearance. Management starts with fasting or a low-fat, medium-chain triglyceride diet or total parenteral nutrition, plus drainage, proceeding to surgical ligation only if that fails. The whole chapter turns on a single axis: the stages of the heart and thorax are both small, and every sign should be treated as a bell counting down the seconds — whether the breath sounds are symmetric, which intercostal space carries the murmur, whether there is subcutaneous emphysema, which threshold the chest tube output has crossed. Gather these details together, and they are the order of management itself.

On the screen in the pulmonology clinic, a five-centimeter tumor sits in the periphery of the right upper lobe, sputum cytology negative yet carrying an EGFR mutation, with a brain metastasis already present — the location, the marker, and the direction of spread have already written the answer: adenocarcinoma. In the operating room next door, an aortic valve replacement is underway, the patient's heart arrested in diastole, all the blood in the body bypassing the heart and lungs and flowing through the tubing instead — this is cardiopulmonary bypass. In the anatomy lab next to that, students are counting ribs, true ribs, false ribs, floating ribs, the costal margin running from the seventh to the tenth — this is the skeleton. Three scenes that look unrelated turn out, together, to be a single lung and its skeleton.

The histologic classification of lung cancer comes down to one rule: location determines everything, and once you understand the location, you understand the story. Squamous cell carcinoma hugs the central airway, so central lesions shed easily and sputum cytology has a high yield; the central blood supply is poor, favoring ischemic necrosis, so it readily cavitates, and it is strongly linked to smoking and secretes parathyroid-hormone-related protein, causing hypercalcemia. Adenocarcinoma favors the periphery, so sputum yield is low, hematogenous spread occurs early, and the rate of brain metastasis is higher than in squamous cell carcinoma; its molecular markers are EGFR and ALK, and it is most common in women and never-smokers. Small cell carcinoma sits centrally, doubles extremely fast, and by the time of diagnosis sixty to seventy percent have already spread distantly; paraneoplastic syndromes such as the syndrome of inappropriate antidiuretic hormone secretion, Cushing's syndrome, and Lambert-Eaton myasthenic syndrome love to appear here. Large cell carcinoma sits peripherally, is undifferentiated, and spreads fast. Two local-invasion syndromes are classic: a superior sulcus (Pancoast) tumor invades the brachial plexus and the sympathetic chain, producing Horner's syndrome plus shoulder and arm pain plus hand muscle wasting; superior vena cava syndrome is most often caused by compression from a central small cell carcinoma, presenting with facial and upper-limb swelling and jugular venous distension. Carcinoid syndrome usually only becomes apparent after liver metastasis, because mediators such as serotonin must bypass hepatic metabolism before they can reach the systemic circulation.

The logic of preoperative evaluation for lung resection runs in three layers: overall function, then predicted postoperative value, then see how it performs on exertion (ACCP 2013 now stratifies by ppoFEV1 and ppoDLCO: both above 60% is low risk, either below 30% calls for formal cardiopulmonary exercise testing). First measure overall FEV1 and DLCO; if either is low, calculate the predicted postoperative value; if that is still insufficient, add an exercise test for maximal VO2. An FEV1 above eighty percent predicted, or above two liters, is usually tolerable; a ppo-FEV1 above forty percent is low risk, below thirty percent is high risk; a DLCO below fifty percent significantly raises postoperative risk, and that is when the exercise test should be added. Which lobe matters least to remove? The right middle lobe has the smallest volume, roughly eight to ten percent of the total, so it has the least effect on FEV1 and FVC. One more fact worth memorizing along the way: in obstructive lung disease such as COPD and asthma, the ratio of FEV1 to FVC falls rather than rises, with FEV1 dropping more than FVC; in restrictive disease such as pulmonary fibrosis, FVC falls while the ratio stays normal or rises. As for treatment triage, non-small cell lung cancer is treated primarily with surgery in the early stages, with chemoradiation plus targeted therapy or immunotherapy for advanced disease; small cell lung cancer has almost always spread distantly already, so chemotherapy is the mainstay, with surgery reserved for the rare, very earliest case. The matching question on screening is the one most often gotten wrong: low-dose chest CT is the true screening tool, backed by national lung cancer screening trial evidence for lowering mortality in the high-risk group; PET-CT is a staging tool, not a screening tool, and it carries even more radiation besides.

Think of the cardiopulmonary bypass circuit as one sentence: venous blood is drawn out, the oxygenator adds oxygen and removes CO₂, and an artery line returns it to the aorta, while the heart and lungs sit idle throughout. So the venous cannula sits in the superior and inferior vena cavae or the right atrium, the arterial cannula sits in the ascending aorta, and no cannula goes into the pulmonary artery, because during this period the pulmonary circulation shuts down entirely and the lungs are bypassed — which is exactly what the word "bypass" means. The most frequently tested numerical reasoning concerns hypothermia and perfusion flow: the physiologic chain is that body temperature falls, metabolic rate falls, oxygen consumption falls, and so flow falls too. At normothermia, thirty-seven degrees Celsius, flow runs at about two-point-two to two-point-four liters per minute per square meter; at deep hypothermia, twenty degrees Celsius, only about one to one-point-five liters is needed, so a question that still uses two-point-four at twenty degrees is too high — that is the normothermic value. Anticoagulation requires full-course heparinization, targeting an activated clotting time above four hundred to four hundred eighty seconds, reversed at the end with protamine; myocardial protection relies on clamping the ascending aorta and then infusing high-potassium cardioplegia to arrest the heart in diastole and lower its oxygen demand. The core of every complication is that the instant blood touches a foreign surface, it triggers inflammation and clotting, so cardiopulmonary bypass inevitably provokes some degree of systemic inflammatory response syndrome — "it does not provoke one" is false; other complications include coagulopathy, hemolysis, embolism, and brain or kidney injury, so shorter is always better, generally kept under six hours. The longer the aortic cross-clamp time runs, the higher the risk of postoperative cardiac dysfunction.

The last piece is a tool for localization. The costal margin is formed by the seventh through tenth costal cartilages joined in sequence: true ribs one through seven, false ribs eight through ten, floating ribs eleven and twelve. The intercostal neurovascular bundle is arranged, top to bottom, as vein, artery, nerve, running inside the costal groove along the inferior border of the rib, so a chest tube or thoracentesis needle should enter along the superior border of the rib, avoiding the bundle below; the lateral cutaneous branch emerges near the midaxillary line; the brachiocephalic trunk gives off no intercostal arteries. The arrangement of the hilum differs between the two sides: in the left hilum the pulmonary artery sits highest, in the right hilum the main bronchus sits highest, and front to back on both sides the pulmonary vein is most anterior and the bronchus most posterior. In front of the transverse pericardial sinus is the arterial group — the ascending aorta and the pulmonary trunk — and behind it is the venous group; the only direct branches of the ascending aorta are the left and right coronary arteries, arising from the aortic sinuses, while the brachiocephalic trunk, the left common carotid, and the left subclavian all branch off the aortic arch instead. The right phrenic nerve descends along the lateral side of the superior vena cava down to the diaphragm, while the left phrenic nerve descends along the lateral side of the pericardium; the right recurrent laryngeal nerve loops under the right subclavian artery, the left loops under the aortic arch, and compression by a mediastinal tumor or an aortic aneurysm produces hoarseness, more often on the left because its path runs longer. The auscultation projections of the heart valves are memorized clockwise from the upper right: the aortic valve at the right second intercostal space, the pulmonary valve at the left second intercostal space, the tricuspid valve at the lower left sternal border, the mitral valve at the apex. The most frequently tested matching point is that the auscultation site and the anatomic projection do not sit in the same place: the pulmonary valve is auscultated at the left second intercostal space, while its anatomic projection sits at the left third costal cartilage; when a question asks for the auscultation site, answer the second intercostal space, and when it asks for the valve's surface anatomic projection, answer the third costal cartilage instead — these are two different questions, so never write the projection as if it were the auscultation site. The whole chapter holds to a single axis: the lung and its skeleton are the deck, the engine, and the frame of the same ship — histologic type decides the direction of spread, temperature decides the flow rate, and anatomy decides where the needle goes in. Get these three sentences straight, and the final mile of the thoracic chapter is complete.